Navigation Links
NREL reports 31.1 percent efficiency for III-V solar cell
Date:6/25/2013

The Energy Department's National Renewable Energy Lab has announced a world record of 31.1% conversion efficiency for a two-junction solar cell under one sun of illumination.

NREL Scientist Myles Steiner announced the new record June 19 at the 39th IEEE Photovoltaic Specialists Conference in Tampa, Fla. The previous record of 30.8% efficiency was held by Alta Devices.

The tandem cell was made of a gallium indium phosphide cell atop a gallium arsenide cell, has an area of about 0.25 square centimeters and was measured under the AM1.5 global spectrum at 1,000 W/m2. It was grown inverted, similar to the NREL-developed inverted metamorphic multi-junction (IMM) solar cell and flipped during processing. The cell was covered on the front with a bilayer anti-reflection coating, and on the back with a highly reflective gold contact layer.

The work was done at NREL as part of DOE's Foundation Program to Advance Cell Efficiency (F-PACE), a project of the Department's SunShot Initiative that aims to lower the cost of solar energy to a point at which it is competitive with other sources including fossil fuels.

At the beginning of the F-PACE project, which aims to produce a 48%-efficient concentrator cell, NREL's best single-junction gallium-arsenide solar cell was 25.7% efficient. This efficiency has been improved upon by other labs over the years: Alta Devices set a series of records, increasing the gallium-arsenide record efficiency from 26.4% in 2010 to 28.8% in 2012. Alta's then-record two-junction 30.8% efficient cell was achieved just two months ago. The new record may not last long either, but "it brings us one step closer to the 48% milestone," said NREL Principal Scientist Sarah Kurtz, who leads the F-PACE project in NREL's National Center for Photovoltaics. "This joint project with the University of California, Berkeley and Spectrolab has provided us the opportunity to look at these near-perfect cells in different ways. Myles Steiner, John Geisz, Ivn Garca and the III-V multijunction PV group have implemented new approaches providing a substantial improvement over NREL's previous results."

"Historically, scientists have bumped up the performance of multijunction cells by gradually improving the material quality and the internal electrical properties of the junctions -- and by optimizing variables such as the bandgaps and the layer thicknesses," NREL Scientist Myles Steiner said. But internal optics plays an underappreciated role in high-quality cells that use materials from the third and fifth columns of the periodic tables the III-V cells. "The scientific goal of this project is to understand and harness the internal optics," he said.

When an electron-hole pair recombines, a photon can be produced, and if that photon escapes the cell, luminescence is observed that is the mechanism by which light-emitting diodes work. In traditional single-junction gallium-arsenide cells, however, most of the photons are simply absorbed in the cell's substrate and are lost. With a more optimal cell design, the photons can be re-absorbed within the solar cell to create new electron-hole pairs, leading to an increase in voltage and conversion efficiency. In a multijunction cell, the photons can also couple to a lower bandgap junction, generating additional current, a process known as luminescent coupling.

The NREL researchers improved the cell's efficiency by enhancing the photon recycling in the lower, gallium-arsenide junction by using a gold back contact to reflect photons back into the cell, and by allowing a significant fraction of the luminescence from the upper, GaInP junction to couple into the GaAs junction. Both the open-circuit voltage and the short-circuit current were increased.

Silicon solar cells now dominate the world PV market, but researchers see opportunities for new materials. High-efficiency concentrator cells bolstered by lenses that magnify the power of the sun are attracting interest from utilities because the modules have demonstrated efficiencies well over 30%. And there may be commercial opportunities for one-sun or low-concentration III-V cells if growth rates can be increased and costs reduced.

The same cell should work well when lenses are added to multiply the sun's power. "We expect to observe similar enhancements of the solar cell characteristics when measured under concentrated illumination," Steiner said.


'/>"/>

Contact: David Glickson
david.glickson@nrel.gov
303-275-4097
DOE/National Renewable Energy Laboratory
Source:Eurekalert

Related biology technology :

1. China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013
2. DNA Sequencing Market 2013 Developments & 2016 Product Forecasts in New Research Reports at ReportsnReports.com
3. Z Trim Holdings Reports Continued Sales Growth in May 2013
4. GW Pharmaceuticals plc Reports 2013 Second Quarter Financial Results
5. CTI Reports Final Results from Cooperative Group and NCI-Sponsored Trial of Brostallicin in Patients with Metastatic Triple-Negative Breast Cancer
6. Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com
7. Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy
8. Vermillion Reports First Quarter 2013 Results
9. Dyadic International Reports First Quarter 2013 Financial Results
10. Neuralstem Reports First Quarter Financial Results And Provides Business And Clinical Update
11. Inovio Pharmaceuticals Reports 2013 First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... RADNOR, Pa., Feb. 24, 2017  VWR Corporation (NASDAQ: VWR), ... to laboratory and production customers, today reported its financial results ... 2016. Highlights: 4Q16 record ... up 1.0% on an organic basis. ... on an organic basis, while the Americas net sales increased ...
(Date:2/23/2017)... Financial ... data, unaudited)Three Months Ended December 31,Twelve Months Ended December ... $           300$ ... Net Product Revenue 3539(10)%9498(4)%Kuvan Net ... Revenue  756025%297303(2)%Vimizim Net Product Revenue ...
(Date:2/23/2017)... , Feb. 23, 2017  MIODx announced ... for two key immunotherapy technologies from the University ... provides a method to monitor a patient for ... PD-L1 and CTLA-4.  The second license extends the ... patient is likely to have an immune-related adverse ...
(Date:2/23/2017)... Feb. 23, 2017  Imanis Life Sciences announced ... of oncolytic vaccinia viruses for virotherapy research. These ... of Genelux,s proprietary, vaccinia virus-based technology platform for ... enter into a partnership with Genelux to offer ... viruses for use in research," said Dr. ...
Breaking Biology Technology:
(Date:2/7/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), ... the LEERINK Partners 6th Annual Global Healthcare Conference at ... 15, 2017 at 10 a.m. Eastern Time. ... accessed at http://wsw.com/webcast/leerink28/zbh .  The webcast will be ... Investor Relations website at http://investor.zimmerbiomet.com . ...
(Date:2/2/2017)... JACKSONVILLE, Fla. , Feb. 2, 2017 /PRNewswire/ ... ), a clinical-stage immuno-oncology company specializing in the ... vaccines for the treatment of cancer and metastatic ... multi-gram scale-up and GMP manufacturing of a second ... T-cell vaccine targeting folate receptor alpha. The manufactured ...
(Date:1/30/2017)... FRANCISCO , Jan. 30, 2017   Invitae ... the fastest growing genetic information companies, today announced that ... financial results and provide 2017 guidance on Monday, February ... conference call that day at 4:45 p.m. Eastern / ... Invitae,s management team will briefly review financial results, guidance, ...
Breaking Biology News(10 mins):